Skip to content
value.today

Accipiter Biosciences Inc.

🇺🇸 Seattle, Washington, USABiotechnologyFounded 2023
Total raised
$24 M
2 rounds on record
Latest round
$10 M
Jul 2026
First round on record
May 2024
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Accipiter Biosciences Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2026$10 MNo. 2$10 to $50 million

Accipiter Biosciences Inc.: Raise no. 2, Jul 2026

Investors in this round

9 investors had bought by the notice of Jul 28, 2026: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hector De Jesus Rincon Arano · Executive Officer, Director, Promoter
  • Javier Castellanos · Executive Officer, Director, Promoter
  • Matthew Bick · Executive Officer, Director, Promoter
  • William Canestaro · Executive Officer
  • Heather Redman · Director
  • Jose Antonio Mesa Cejudo · Director
  • Randall Schatzman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matthew Bick, Chief Executive Officer. Newest notice filed Jul 28, 2026. Read the notice at the SEC.

equitySEC
May 2024$14 MNo. 1$10 to $50 million

Accipiter Biosciences Inc.: Raise no. 1, May 2024

Investors in this round

15 investors had bought by the notice of Sep 24, 2025: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Hector De Jesus Rincon Arano · Executive Officer, Promoter
  • Javier Castellanos · Executive Officer, Director, Promoter
  • Matthew Bick · Executive Officer, Director, Promoter
  • Heather Gorham · Director
  • Jiaping Gu · Director
  • Jose Antonio Mesa Cejudo · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Matthew Bick, Chief Executive Officer. Newest notice filed Sep 24, 2025 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Accipiter Biosciences Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2026).

    SEC Form D · Jul 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jul 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Accipiter Biosciences Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Accipiter Biosciences Inc.
NameRoleNamed in
Hector De Jesus Rincon AranoExecutive officerJul 2026
Javier CastellanosExecutive officerJul 2026
Matthew BickExecutive officerJul 2026
William CanestaroExecutive officerJul 2026
Heather RedmanDirectorJul 2026
Hector De Jesus Rincon AranoDirectorJul 2026
Javier CastellanosDirectorJul 2026
Jose Antonio Mesa CejudoDirectorJul 2026
Matthew BickDirectorJul 2026
Randall SchatzmanDirectorJul 2026
Heather GorhamDirectorSep 2025
Jiaping GuDirectorSep 2025
Hector De Jesus Rincon AranoPromoterJul 2026
Javier CastellanosPromoterJul 2026
Matthew BickPromoterJul 2026